LRG1 and metastatic prostate carcinoma: These implicate a significant biological role of LRG1 in inflammation but also several important hallmarks of cancer development and progression, which might shed light on the highly diverse outcomes among patients diagnosed with high-risk and metastatic prostate cancer.